Cargando…
Targeting BPOZ-2 in Lewy body disease
Autor principal: | Roy, Avik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962582/ https://www.ncbi.nlm.nih.gov/pubmed/27482213 http://dx.doi.org/10.4103/1673-5374.184483 |
Ejemplares similares
-
BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson’s Disease
por: Roy, Avik, et al.
Publicado: (2016) -
Advancing the Genetics of Lewy Body Disorders with Disease‐Modifying Treatments in Mind
por: Levy, Gilberto, et al.
Publicado: (2022) -
BPOZ-2 is a negative regulator of the NLPR3 inflammasome contributing to SARS-CoV-2-induced hyperinflammation
por: Li, Jingfei, et al.
Publicado: (2023) -
Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel
por: Sabbagh, Marwan N., et al.
Publicado: (2023) -
Lewy body disease or diseases with Lewy bodies?
por: Menšíková, Kateřina, et al.
Publicado: (2022)